MedPath

Study conducted in a tertiary care hospital for a period of one year, aims to observe the number of new cases and better understand the treatment of infections caused by bacteria belonging to Enterobacteriaceae species that are resistant to an antibiotic class called Carbapenems.

Not yet recruiting
Conditions
Pneumonia due to Klebsiella pneumoniae, (2) ICD-10 Condition: A415||Sepsis due to other Gram-negativeorganisms, (3) ICD-10 Condition: N390||Urinary tract infection, site notspecified,
Registration Number
CTRI/2023/04/051953
Lead Sponsor
Gaurav Girish
Brief Summary

THE MAIN OBJECTIVE IS TO DETERMINE CRE INCIDENCE IN A SOUTH INDIAN TERTIARY CARE HOSPITAL

THE SECONDARY OBJECTIVE IS TO COMPARE THE MANAGEMENT OF CURRENT TREATMENT VS ICMR GUIDELINES

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
139
Inclusion Criteria

ADULT PATIENT WITH CRE INFECTION CAUSED BY E.COLI OR K.PNEUMONIAE.

Exclusion Criteria

PATIENTS WHO DO NOT PROVIDE CONSENT.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
INCIDENCE OF CRE INFECTIONS and COMPARISION OF MANAGEMENT GUIDELINES FOLLOWED IN TERTIARY CARE HOSPITAL WITH ICMR GUIDELINESApril 2023 to March 2024
Secondary Outcome Measures
NameTimeMethod
COMPARISION OF MANAGEMENT WITH ICMR GUIDELINESMAY 2023 TO MAY 2024

Trial Locations

Locations (1)

KASTURBA HOSPITAL

🇮🇳

Udupi, KARNATAKA, India

KASTURBA HOSPITAL
🇮🇳Udupi, KARNATAKA, India
Gaurav Girish
Principal investigator
06362262070
gaurav.girish1@learner.manipal.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.